CalciMedica is engaged in the discovery and development of small molecule drugs for the treatment of inflammatory and autoimmune disorders. Founded by Gonul Velicelebi, Jack Roos, and Kenneth A. Stauderman in 2006, CalciMedica is backed by investors that include Bering Capital, SR One, Biogen Idec, Sanderling Ventures, and Mesa Verde Venture Partners and is headquartered in La Jolla.